5AM Ventures IV, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for 5AM Ventures IV, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of 5AM Ventures IV, L.P.. 5AM Ventures IV, L.P. is 10% Owner in Homology Medicines, Inc. ($FIXX) and in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and in Aprea Therapeutics, Inc. ($APRE) and 10% Owner in Aprea Therapeutics, Inc. ($APRE).
Latest Insider Trading Transactions of 5AM Ventures IV, L.P.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APRE, CRNX, FIXX, IDYA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 28 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 12.82 | 20,000 | 256,400 | 181,435 | 201.4 K to 181.4 K (-9.93 %) |
Dec 28 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 12.82 | 480,000 | 6,153,600 | 4,354,484 | 4.8 M to 4.4 M (-9.93 %) |
Dec 16 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 11.88 | 13,703 | 162,792 | 201,435 | 215.1 K to 201.4 K (-6.37 %) |
Dec 16 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 13.06 | 6,297 | 82,244 | 215,138 | 221.4 K to 215.1 K (-2.84 %) |
Dec 16 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 11.88 | 328,862 | 3,906,881 | 4,834,484 | 5.2 M to 4.8 M (-6.37 %) |
Dec 16 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 13.06 | 151,138 | 1,973,998 | 5,163,346 | 5.3 M to 5.2 M (-2.84 %) |
Nov 13 2020 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 13.66 | 115,504 | 1,577,785 | 384,496 | 500 K to 384.5 K (-23.10 %) |
Nov 13 2020 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 13.66 | 27,379 | 373,997 | 91,142 | 118.5 K to 91.1 K (-23.10 %) |
Nov 13 2020 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 13.66 | 657,117 | 8,976,218 | 2,187,428 | 2.8 M to 2.2 M (-23.10 %) |
Oct 07 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | Sell | S | 25.30 | 175,000 | 4,427,500 | 138,497 | 313.5 K to 138.5 K (-55.82 %) | |
Oct 07 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | Sell | S | 25.30 | 175,000 | 4,427,500 | 138,497 | 313.5 K to 138.5 K (-55.82 %) | |
Jun 18 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 33.30 | 19,836 | 660,539 | 313,497 | 333.3 K to 313.5 K (-5.95 %) |
Jun 18 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 33.30 | 4,807 | 160,073 | 75,965 | 80.8 K to 76 K (-5.95 %) |
Jun 18 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 33.30 | 115,357 | 3,841,388 | 1,823,192 | 1.9 M to 1.8 M (-5.95 %) |
Jun 15 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 28.75 | 9,800 | 281,776 | 80,772 | 90.6 K to 80.8 K (-10.82 %) |
Jun 15 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 28.75 | 235,200 | 6,762,635 | 1,938,549 | 2.2 M to 1.9 M (-10.82 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |
Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 20,519 | 0 | 0 | |
Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 492,475 | 0 | 0 | |
Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 79,746 | 0 | 0 | |
Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,913,910 | 0 | 0 | |
Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | P | 15.00 | 333,333 | 4,999,995 | 333,333 | 0 to 333.3 K |
Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 20,519 | 0 | 100,772 | 80.3 K to 100.8 K (+25.57 %) |
Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 492,475 | 0 | 2,418,548 | 1.9 M to 2.4 M (+25.57 %) |
Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 79,746 | 0 | 80,253 | 507 to 80.3 K (+15,728.99 %) |
Oct 09 2019 | APRE | Aprea Therapeutics ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 1,913,910 | 0 | 1,926,073 | 12.2 K to 1.9 M (+15,735.51 %) |
Jun 25 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | Sell | S | 22.20 | 10,000 | 222,000 | 94,489 | 104.5 K to 94.5 K (-9.57 %) | |
Jun 25 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | Sell | S | 22.20 | 240,000 | 5,328,000 | 2,267,797 | 2.5 M to 2.3 M (-9.57 %) | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 24,101 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 71,745 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 578,447 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,721,898 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 500,000 | 0 to 500 K |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | P | 10.00 | 10,000 | 100,000 | 118,521 | 108.5 K to 118.5 K (+9.21 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | P | 10.00 | 240,000 | 2,400,000 | 2,844,545 | 2.6 M to 2.8 M (+9.21 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 24,101 | 0 | 108,521 | 84.4 K to 108.5 K (+28.55 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 71,745 | 0 | 84,420 | 12.7 K to 84.4 K (+566.04 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 578,447 | 0 | 2,604,545 | 2 M to 2.6 M (+28.55 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 1,721,898 | 0 | 2,026,098 | 304.2 K to 2 M (+566.04 %) |
May 20 2019 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 21.47 | 24,600 | 528,162 | 221,435 | 246 K to 221.4 K (-10.00 %) |
May 20 2019 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 21.47 | 590,400 | 12,675,888 | 5,314,484 | 5.9 M to 5.3 M (-10.00 %) |
Mar 20 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 24.25 | 6,194 | 150,209 | 104,489 | 110.7 K to 104.5 K (-5.60 %) |
Mar 20 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 24.25 | 148,645 | 3,604,745 | 2,507,797 | 2.7 M to 2.5 M (-5.60 %) |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | J | 0.00 | 783 | 0 | 1,723 | 940 to 1.7 K (+83.30 %) |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | J | 0.00 | 783 | 0 | 1,723 | 940 to 1.7 K (+83.30 %) |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | J | 0.00 | 783 | 0 | 1,723 | 940 to 1.7 K (+83.30 %) |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | J | 0.00 | 587 | 0 | 940 | 353 to 940 (+166.29 %) |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | J | 0.00 | 353 | 0 | 353 | 0 to 353 |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | J | 0.00 | 940 | 0 | 940 | 0 to 940 |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | J | 0.00 | 940 | 0 | 940 | 0 to 940 |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | J | 0.00 | 4,700 | 0 | 0 | 4.7 K to 0 (-100.00 %) |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | J | 0.00 | 4,700 | 0 | 4,700 | 0 to 4.7 K |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | J | 0.00 | 18,800 | 0 | 110,683 | 129.5 K to 110.7 K (-14.52 %) |
Feb 22 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | J | 0.00 | 451,200 | 0 | 2,656,442 | 3.1 M to 2.7 M (-14.52 %) |
Jan 24 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 21.88 | 10,486 | 229,381 | 129,483 | 140 K to 129.5 K (-7.49 %) |
Jan 24 2019 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 21.88 | 251,667 | 5,505,216 | 3,107,642 | 3.4 M to 3.1 M (-7.49 %) |
Dec 12 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 26.01 | 623 | 16,201 | 246,035 | 246.7 K to 246 K (-0.25 %) |
Dec 12 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 26.01 | 14,952 | 388,828 | 5,904,884 | 5.9 M to 5.9 M (-0.25 %) |
Nov 27 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 20.04 | 1,187 | 23,783 | 246,658 | 247.8 K to 246.7 K (-0.48 %) |
Nov 27 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 20.04 | 28,495 | 570,926 | 5,919,836 | 5.9 M to 5.9 M (-0.48 %) |
Nov 20 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 20.20 | 21,036 | 424,927 | 247,845 | 268.9 K to 247.8 K (-7.82 %) |
Nov 20 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 20.20 | 504,864 | 10,198,253 | 5,948,331 | 6.5 M to 5.9 M (-7.82 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 61,861 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 383,507 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,484,690 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,204,220 | 0 | 0 | |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | P | 17.00 | 4,600 | 78,200 | 139,969 | 135.4 K to 140 K (+3.40 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | P | 17.00 | 110,400 | 1,876,800 | 3,359,309 | 3.2 M to 3.4 M (+3.40 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 18,802 | 0 | 135,369 | 116.6 K to 135.4 K (+16.13 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 116,567 | 0 | 116,567 | 0 to 116.6 K |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 451,274 | 0 | 3,248,909 | 2.8 M to 3.2 M (+16.13 %) |
Jul 20 2018 | CRNX | Crinetics Pharmace ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 2,797,635 | 0 | 2,797,635 | 0 to 2.8 M |
Apr 04 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,187,535 | 0 | 0 | |
Apr 04 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,204,502 | 0 | 0 | |
Apr 04 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 5,392,037 | 0 | 6,722,076 | 1.3 M to 6.7 M (+405.40 %) |
Page: 1